Room For Improvement
India’s Clinical Infrastructure
Growth is outstripping electrical, medical and staffing capacity in this hot market for clinical trials. That imposes extra costs.
The recruitment of minority patients is hard under any circumstances. But finding research subjects for conditions with a social stigma is especially difficult. Barbara Gladson is director of the biopharma educational initiative at the University of Medicine and Dentistry of New Jersey (UMDNJ). She gave a fascinating presentation on her work at the 2010 annual Drug Information Association (DIA) meeting in Washington, D.C. Gladson is assisting on hepatitis and liver-related trials in the Newark, New Jersey facility. Through the UMDNJ foundation, she's also seeking grants from federal and industry sources for other conditions, including diabetes and hypertension. In cancer trials at UMDNJ during 2007, Gladson related, twenty African-American patients out of 396 with the disease were enrolled, a 5.1 percent rate. Among Latinos, 12 patients enrolled out of 260 with cancer, a rate of 4.6 percent. That was a wake up call. “It should have been much more ethnically diverse,” Gladson…more...
Large life science companies have fired untold tens of thousands of employees during every year of the ongoing downturn—a period of both financial chaos and pharmaceutical mega-mergers. Here's one estimate, and…more...
Within the sprawling Loma Linda Veterans Healthcare System in Redlands, California, sits the non-profit research arm Loma Linda Veterans Association for Research and Education , and in a corner of its…more...
In watching respiratory therapists recruit for two studies under way in her departments at both Mount Sinai Hospital and SickKids Hospital in Toronto, neonatologist Sharon Unger thought she saw a trend.…more...
Last month, BBK Worldwide, a technology-savvy patient recruitment firm, opened a new office in Los Angeles to complement headquarters in Boston and satellite locations in London, Prague and Osaka. Biotechnology companies of all sizes, in Los Angeles and San Diego, were the draw for the new location. But for Bonnie Brescia, a founding principal of the company,…more...
As a large commercial site, how do you get all your investigators to truly support what you're doing? By inviting them to actually buy in. That's what Jacksonville Center for Clinical Research did in 1997 when it spun off from a cardiology practice. “Doctors were given the choice of continuing to just be principal investigators or buying…more...
If the International Alliance of Patients Organizations (IAPO) gets its way, patients will soon sit at the table with scientists to offer input into the design of study protocols. Not in a forceful or adversarial way, says Jeremiah Mwangi, IAPO's senior policy officer, but in a way that benefits everyone. Picture, for example, a pediatric epilepsy trial…more...
If one wants to launch a study on a treatment for Type 2 diabetes, and one desires to know how long it will take to enroll patients in, say, Brazil vs. India, the avenues for obtaining that information have been limited. Not anymore. The consulting, benchmarking and analytics firm KMR Group has launched a service called SiteView that…more...
Growth is outstripping electrical, medical and staffing capacity in this hot market for clinical trials. That imposes extra costs.
Acusphere’s loss is WorldCare’s gain, as three new executives sign on.
BBK Worldwide discusses how to find patients for the most problematic trials.
iGuard expected to draw 60,000 members in a year. Instead, it attracted 750,000. The coming shift in strategy—and genomics.
Things are still going well at CRN, which relies on a network of nurses that can visit patients at home.
The patient-recruitment firm talks about using the right data and spending what is necessary.
The health outcomes division of the i3 brand discusses trials that are professionally designed and run on the computer.
Organizations
Conferences
Info & Opinion
© 2010 ClinPage. All Rights Reserved.